Ashwath Gurumurthi
Hematology | Oncology | Transplant Surgery
86 Jonathan Lucas St
2nd Floor, 3rd Floor
Charleston, SC 29425
2nd Floor, 3rd Floor
Charleston, SC 29425
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Analysis of Social Drivers of Health, Race, and Ethnicity With Survival in Myeloma Patients.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 28, 2025
Pneumocystis jirovecii pneumonia with use of brentuximab vedotin in treatment-naïve Hodgkin lymphoma.
Journal: Leukemia & lymphoma
Published: February 24, 2025
A phase 1 trial of abexinostat with ibrutinib in relapsed/refractory mantle cell lymphoma and non-germinal center diffuse large B cell lymphoma.
Journal: Leukemia & lymphoma
Published: September 20, 2024
New treatments for adult T-cell leukemia/lymphoma.
Journal: Leukemia research
Published: September 12, 2024
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma.
Journal: Blood
Published: September 05, 2024
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers.
Journal: Haematologica
Published: June 06, 2024
Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial.
Journal: EClinicalMedicine
Published: April 03, 2024
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement.
Journal: Leukemia & lymphoma
Published: January 22, 2024
The race is on: bispecifics vs CAR T cells in B-cell lymphoma.
Journal: Blood advances
Published: January 23, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026